Buy (150 RUB)
|Generate QR code
Open Access
Subscription or Fee Access
Respiratory system involvement in rheumatic diseases: literature analysis and original data
https://doi.org/10.33667/2078-5631-2024-29-7-12
Abstract
The article presents the data of current publications on the problem of respiratory lesions in immune-mediated inflammatory rheumatic diseases and the results of our own studies on the frequency and spectrum of bronchopulmonary pathology in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), systemic connective tissue diseases, and ANCA vasculitis. Respiratory system lesions are detected in 24.5–70.2 % of patients with inflammatory RD according to different authors. Interstitial lung diseases, pulmonary fibrosis, and bronchial obstruction prevail in the structure of respiratory disorders. Polymorphism of pulmonary manifestations of RD includes pulmonary hypertension, which is recorded in more than a third of patients with systemic connective tissue diseases. As our own clinical data showed, respiratory lesions occurred in 33 people (27.5 %) out of 120 patients with immune-mediated inflammatory RD. The leading form of damage was interstitial pneumonia and interstitial pulmonary fibrosis. Among the patients with determined lung involvement were individuals with RA, SSc, ANCA vasculitis, AS and Sjogren's disease. The article presents a clinical case of the interstitial pneumonia in a patient with RA. The contribution of uncontrolled rheumatoid inflammation and disease-modifying therapy to the manifestation of pulmonary involvement is discussed. The positive effect of IL-6 inhibitor in abolishing RA activity and pulmonary lesion is shown.
About the Authors
E. V. Kalinina
Volgograd State Medical University
Russian Federation
Russian Federation
Elena V. Kalinina, PhD Med, associate professor, associate professor at Dept
Dept of Faculty Therapy
Volgograd
V. P. Goloskova
Volgograd State Medical University
Russian Federation
Russian Federation
Victoria P. Goloskova, clinical resident in the internal diseases speciality
Institute of Continuing Medical and Pharmaceutical Education
Volgograd
A. R. Babaeva
Volgograd State Medical University
Russian Federation
Russian Federation
Aida R. Babaeva, DM Sci (habil.), professor, head of Dept
Dept of Faculty Therapy
Volgograd
References
1. Nasonov E. L., Gordeev A. V., Galushko E. A. Rheumatic diseases and multi-morbidity. Therapeutic Archive. 2015; 87 (5): 4–9.
2. Bestaev D. V., Karateev D. E., Nasonov E. L. Lung damage in rheumatoid arthritis. Scientific and practical rheumatology. 2014; 52б (4): 451–457.
3. Pinheiro FA, Souza DC, Sato EI. A study of multiple causes of death in rheumatoid arthritis. The Journal of Rheumatology 2015 Dec;42(12):2221–8
4. Nasonov E. L., Ananyeva L. P., Avdeev S. N. Interstitial lung diseases in rheumatoid arthritis: a multidisciplinary problem of rheumatology and pulmonology. Scientific and practical rheumatology. 2022; 60 (6): 517–534.
5. Ananyeva L. P. Chronic fibrotic interstitial lung diseases with progressive phenotype. Ananyeva L. P. [et al.]. Scientific and practical rheumatology. 2020; 58 (6): 631–636.
6. Conforti A, Di Cola I, Pavlych V, Ruscitti P, Berardicurti O, Ursini F, Giacomelli R, Cipriani P. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmunity Reviews 2021 Feb; 20 (2): 102735.
7. Tanaka A. et al. Cluster analysis of pulmonary lesions in RA: airway disease is shared and critical pulmonary abnormality in RA/ DOI: 10.1136/annrheumdis-2017-eular.5828
8. Halidou AR. et al. Pulmonary involvement in Rheumatoid arthritis and secondary Sjogren syndrome. DOI: 10/1136/annrheumdis-2022-eular.630
9. Winter L. et al. BONN Pulsa: pulmonary screening in arthritis – prevalence of pulmonary manifestations in patients with newly diagnosed rheumatoid arthritis, psoriatic arthritis, and peripheral spondyloarthritis. DOI: 10.1136/annrheumdis-2023-eular.2221
10. Uzun G. S. et al. Progression of rheumatoid pulmonary nodules: what are the predictive factors? DOI: 10.1136/annrheumdis-2023-eular.1945
11. El Maghraoui A. Extraarticular manifestations of ankylosing spondylitis: Prevalence, characteristics and therapeutic implications. Eur. J. Intern. Med. 2011; 22 (6): 554–560. DOI: 10.1016/j.ejim.2011.06.006
12. Kanathur N., Lee Chiong T. Pulmonary manifestations of ankylosing spondylitis. Clin. Chest Med. 2010; 31 (3): 547–554. DOI: 10.1016/j.ccm.2010.05.002
13. Trofimenko I. N., Nashatyreva M. S., Chernyak B. A. Lung damage in ankylosing spondylitis. Pulmonology. 2017; 27 (1): 97–102. DOI: 10.18093/08690189201727197102
14. Rodrigez J. E.O. et al. Pulmonary involvement and functional limitation in Systemic sclerosis. DOI: 10.1136/annrheumdis-2019-eular.6576
15. Ananyeva L. P. Diagnosis and treatment of interstitial lung damage in systemic scleroderma. Modern rheumatology. 2018; 12 (2): 12–21. DOI: 10.14412/1996-7012-2018-2-12-21
16. Lesnyak V. N., Ananyeva L. P., Koneva O. A. and others. Semi-quantitative visual methods for assessing the severity of interstitial lung lesions according to computed tomography in systemic scleroderma. Pulmonology. 2017; 27 (1): 41–50. DOI: 10.18093/0869-0189-2017-27-1-41-50
17. Cottin V. Idiopathic interstitial pneumonias with connective tissue diseases features : a review. Respirology. 2016; 21 (2): 245–258. DOI: 10.1111/resp.12588
18. Nashatyreva M. S., Trofimenko I. N., Chernyak B. A. Interstitial lung lesion in systemic scleroderma (literature review and own clinical observation). Pulmonology. 2020; 30 (1): 102–108. DOI: 10.18093/0869-0189-2020-30-1-102-108
19. Anaev E. H. Pulmonary vasculitis: differential diagnosis. Practical pulmonology. 2017; 1: 51–57.
20. Voloshinova E.V., Karoli N.A., Nikitina N.M., Makhina V.I., Rebrov A.P. Features of the course and organ damage in ANCA-associated vasculitis. (In Russ.). Therapy. 2019; 2 (28): 110–116. doi: 10.18565/therapy.2019.2.110-116
21. Kreider M., Highland K. Pulmonary involvement in Sjögren syndrome. Semin Respir Crit Care Med 2014; 35: 255–264.
22. Flament T., Bigot A., Chaigne B., Henique H. Pulmonary manifestations of Sjögren's syndrome. European Respiratory Review 2016; 25: 110–178.
23. Cornec D., Devauchelle-Pensec V., Tobón G. J. et al. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment. J. Autoimmun. 2012; 39: 161–167.
24. Amri R. et al. Epidemiological profile of the pulmonary diseases in mixed connective tissue disease: about 55 cases. DOI: 10.1136/annrheumdis-2017-eular.6207
25. Li Z. et al. Imaging manifestations of pulmonary involvement in Takayasu arteritis. DOI: 10.1136/annrheumdis-2020-eular.5102
26. Azpiri-Lopez J.R. et al. Pulmonary hypertension among Hispanic patients with rheumatoid arthritis. DOI: 10.1136/annrheumdis-2018-eular.7184
27. Sami F. et al. Pulmonary arterial hypertension in Systemic sclerosis: a national inpatient analysis. DOI: 10.1136/annrheumdis-2023-eular.333
28. Gulle S. et al. Baricitinib ameliorates bleomycin-induced pulmonary and skin fibrosis via JAK1/2 inhibition. DOI: 10.1136/annrheumdis-2023-eular.5329
Review
For citations:
Kalinina E.V., Goloskova V.P., Babaeva A.R. Respiratory system involvement in rheumatic diseases: literature analysis and original data. Medical alphabet. 2024;(29):7-12. (In Russ.) https://doi.org/10.33667/2078-5631-2024-29-7-12
Views:
389
Email this article 